Clinical presentations and outcomes of digoxin intoxicated patients


  • Komsing Methavigul, M.D. Department of Cardiology, Central Chest Institute of Thailand
  • Summon Chomchai, M.D. Department of Medicine, Faculty of Medicine, Siriraj Hospital


digoxin toxicity, digitalis toxicity, atrial fibrillation, complete heart block


Background: A recent report from Holmes suggested that the optimal screening age should be around five years old. The preschool vision screening is essential and should be included in the vision screening program in Thailand. The objective of this study was to assess the agreement of the interpretation of preschool visual acuity among doctor screeners and a teacher screener. Methods: The study was performed between August and October 2011. Preschool children aged between 36 and 72 months old from 3 Child Care Centres (CCC) were enrolled. All participants were tested for visual acuity (VA) by a combination of the following screeners: a third-year resident, a teacher from one of the CCCs who has been trained in VA measurement, and two ophthalmologists each with over 10 years’ experience. The VA measurement was carried out in pairs as follows: an ophthalmologist with the resident, an ophthalmologist with the teacher and the resident with the teacher. Results: Two hundred and sixty-four eyes (132 patients) met the criteria. The mean age of the preschool children was 43.71±4.54 months (range, 51-36 months). The agreement rates among the three pairs that carried out VA screening were excellent (k=0.81), moderate (k=0.63) and good (k=0.75) respectively. Conclusion: A teacher trained in VA measurement reliably measured VA in preschool children when compared to ophthalmologists.


Download data is not yet available.


Ismail N. Digitalis (cardiac glycoside) intoxication [Internet].2008[cited 2008 Jan 23]; available from

Poole-Wilson PA, Opie LH. Acute and Chronic Heart Failure:Positive Inotropes, Vasodilators, and Digoxin. In: Opie LH, GershBJ, editors. Drugs for the heart. 7th ed. Philadelphia: SaudersElsevier; 2009. p.160-97.

Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, DraznerMH et al. ACCF/AHA guideline for the management of heartfailure. J Am Coll Cardiol. 2013;62(16):e147-239.

Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJet al. ESC Guidelines for the diagnosis and treatment of acuteand chronic heart failure. Eur Heart J. 2016;37(27):2129-200.

January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2014;64(21):e1-76.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al. ESC Guidelines for the management of atrial fibrillation. Eur Heart J. 2016;37(38):2893-962.

Bauer LA. Clinical Pharmacokinetics Handbook International Edition. USA: The McGraw-Hill Companies, Inc; 2006.

Jitapunkul S, Kongsawat V, Sutheparak S. Digoxin toxicity in Thai medical patients: clinical manifestations and an appropriate diagnostic serum level. Southeast Asian J Trop Med Public Health. 2002;33(3):608-12.

Goldberger AL. Basic approach to arrhythmias due to digitalis toxicity [Internet]. 2008 [cited 2008]; available from

Ma G, Brady WJ, Pollack M, Chan TC. Electrocardiographic manifestations: digitalis toxicity. J Emerg Med. 2001;20(2):145-52.

Abad-Santos F, Carcas AJ, Ibáñez C, Frías J. Digoxin level and clinical manifestations as determinants in the diagnosis of digoxin

toxicity. Ther Drug Monit. 2000;22(2):163-8.



How to Cite

เมธาวีกุล ค, โฉมฉาย ส. Clinical presentations and outcomes of digoxin intoxicated patients. j dept med ser [Internet]. 2022 Mar. 31 [cited 2022 Oct. 7];47(1):108-13. Available from:



Original Article